Compare WVE & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | FCEL |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.1M | 1.2B |
| IPO Year | 2015 | 2005 |
| Metric | WVE | FCEL |
|---|---|---|
| Price | $5.22 | $22.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 4 |
| Target Price | ★ $29.81 | $8.31 |
| AVG Volume (30 Days) | 2.9M | ★ 8.3M |
| Earning Date | 04-28-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.24 |
| EPS | ★ N/A | N/A |
| Revenue | $3,704,000.00 | ★ $89,437,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | $85.67 | $42.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.01 | $3.78 |
| 52 Week High | $21.73 | $37.88 |
| Indicator | WVE | FCEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 50.94 |
| Support Level | N/A | $17.33 |
| Resistance Level | $6.39 | $26.16 |
| Average True Range (ATR) | 0.36 | 2.54 |
| MACD | -0.06 | 0.12 |
| Stochastic Oscillator | 16.07 | 47.61 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.